000			02097 a2200613 4500
005			20250515221356.0
264		0	_c20100824
008			201008s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2010-01-261628 _2doi
040			_aNLM _beng _cNLM
100	1		_aLong, Jianting
245	0	0	_aMultiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia. _h[electronic resource]
260			_bBlood _cJul 2010
300			_a71-80 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Cycle Proteins
650	0	4	_aCell Line, Tumor
650	0	4	_aCells, Cultured
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aHumans
650	0	4	_aImidazoles _xpharmacology
650	0	4	_aImmunoblotting
650	0	4	_aIndoles _xpharmacology
650	0	4	_aLeukemia, Myeloid _xgenetics
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNuclear Proteins _xgenetics
650	0	4	_aPiperazines _xpharmacology
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aProto-Oncogene Proteins c-mdm2 _xantagonists & inhibitors
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aSpiro Compounds _xpharmacology
650	0	4	_aTumor Cells, Cultured
650	0	4	_aTumor Suppressor Protein p53 _xgenetics
650	0	4	_aYoung Adult
650	0	4	_afms-Like Tyrosine Kinase 3 _xgenetics
700	1		_aParkin, Brian
700	1		_aOuillette, Peter
700	1		_aBixby, Dale
700	1		_aShedden, Kerby
700	1		_aErba, Harry
700	1		_aWang, Shaomeng
700	1		_aMalek, Sami N
773	0		_tBlood _gvol. 116 _gno. 1 _gp. 71-80
856	4	0	_uhttps://doi.org/10.1182/blood-2010-01-261628 _zAvailable from publisher's website
999			_c19762167 _d19762167